Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?
El Zorkany B, Alwahshi HA, Hammoudeh M, Al Emadi S, Benitha R, Al Awadhi A, Bouajina E, Laatar A, El Badawy S, Al Badi M, Al-Maini M, Al Saleh J, Alswailem R, Ally MM, Batha W, Djoudi H, El Garf A, El Hadidi K, El Marzouqi M, Hadidi M, Maharaj AB, Masri AF, Mofti A, Nahar I, Pettipher CA, Spargo CE, Emery P.
El Zorkany B, et al.
Clin Rheumatol. 2013 Feb;32(2):151-9. doi: 10.1007/s10067-012-2153-7. Epub 2012 Dec 30.
Clin Rheumatol. 2013.
PMID: 23274756
Although the prevalence of RA in the Middle East and Africa is comparable with that in other parts of the world, evidence indicates that its management in this region is suboptimal for a variety of reasons, including misconceptions and misunderstandings about the disease's preval …
Although the prevalence of RA in the Middle East and Africa is comparable with that in other parts of the world, evidence indicates that its …